Nachrichten zur AstraZeneca PLC Aktie

3 Growth Stocks Trading Near Their 52-Week Lows to Buy Right Now

There are plenty of growth stocks trading at obscenely high valuations right now. Part of the reason for that is…

AstraZeneca Is No Longer a Sell for Any Analyst as UBS Upgrades

AstraZeneca Plc’s recent share-price rout has gone so far that the pharma stock has shaken off the last of its…

NATIONAL UNIVERSITY HEALTH SYSTEM, SAHLGRENSKA UNIVERSITY HOSPITAL AND INDUSTRY PARTNERS, ASTRAZENECA AND ERICSSON ESTABLISH GLOBAL HEALTH INNOVATION NETWORK

20 November 2024 SINGAPORE — The National University Health System (NUHS) and Sahlgrenska University Hospital have formed a strategic partnership with…

ANALYSE-FLASH: UBS hebt Astrazeneca auf Neutral - Ziel 11300 Pence

ZÜRICH (dpa-AFX Broker) - Die Schweizer Großbank UBS hat die Aktien von Astrazeneca nach ihrem Kursrutsch bei unverändertem Kursziel…

ANALYSE-FLASH: UBS hebt Astrazeneca auf 'Neutral' - Ziel 11300 Pence

ZÜRICH (dpa-AFX Broker) - Die Schweizer Großbank UBS hat die Aktien von Astrazeneca nach ihrem…

UBS hebt Astrazeneca auf Neutral - Ziel 11300 Pence

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Aktien von Astrazeneca nach ihrem Kursrutsch bei unverändertem Kursziel von…

International business development expert joins Dicot Pharma

Uppsala, Sweden, November 19, 2024. The potency drug developer Dicot Pharma, which recently initiated a phase 2a clinical trial and…

Tagrisso recommended for EU approval - LAURA

18 November 2024 Tagrisso recommended for approval in the EU by CHMP for patients with unresectable EGFR-mutated lung cancer  Recommendation based on LAURA Phase III…

FIVE at FIVE: GSK, AstraZeneca plummet; LandSec profits; Economy stalls; FTSE 100 meanders; TT snubs Volex

1. Trump anti-vax health appointment wipes £7bn from AstraZeneca and GSK President-elect Donald Trump announced the controversial appointment of Robert…

Trump anti-vax health appointment wipes £7bn from AstraZeneca and GSK

Almost £7 billion was wiped from the combined market values of GSK PLC and AstraZeneca PLC on Friday after Donald Trump unveiled his…

Is AstraZeneca a Buy as It Eyes the Weight Loss Market?

AstraZeneca just released some encouraging data about its weight loss drug candidates.…

AstraZeneca: Strong Growth Potential And Market Volatility Offer Opportunity

…

AstraZeneca Aktie: Sorgen um möglichen Skandal in China

Kulmbach (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy

AstraZeneca said it is doubling down on its investment in its U.S. business. Meanwhile, General Catalyst has agreed to purchase…

Deutsche Bank belässt Astrazeneca auf Hold - Ziel 10500 Pence

FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat Astrazeneca auf "Hold" mit einem Kursziel von 10500 Pence belassen. Er habe…

AstraZeneca investiert $3,5 Milliarden in R&D und Produktion in den Vereinigten Staaten

CAMBRIDGE, England--(BUSINESS WIRE)--AstraZeneca hat heute Investitionen von $3,5 Milliarden in den Vereinigten Staaten angekündigt. Bis Ende 2026 sollen dort Forschung…

AstraZeneca Plc (AZN) Q3 2024 Earnings Call Transcript

AZN earnings call for the period ending September 30, 2024.…

AstraZeneca PLC 2024 Q3 - Results - Earnings Call Presentation

…

AstraZeneca PLC (AZN) Q3 2024 Earnings Call Transcript

…

AstraZeneca Talks Up US Growth as China Problems Fester

AstraZeneca Plc is increasingly looking to the US for growth as its once fast-expanding China business slows amid a probe…

AstraZeneca Lifts Outlook, Plans $3.5B US Investment

British drugmaker AstraZeneca increased its full-year sales outlook on booming demand for its cancer and rare-disease drugs, and said it…

Trending tickers: The latest investor updates on Coinbase, Tesla, AstraZeneca, Metro Bank and SoftBank

The latest investor updates on stocks that are trending on Tuesday.…

ROUNDUP: Astrazeneca hebt Jahresziele erneut - Milliardeninvestition in den USA

CAMBRIDGE (dpa-AFX) - Eine hohe Nachfrage vor allem nach seinen Medikamenten gegen Krebs und seltene Krankheiten…

ROUNDUP: Astrazeneca hebt Jahresziele erneut - Milliardeninvestition in den USA

CAMBRIDGE (dpa-AFX) - Eine hohe Nachfrage vor allem nach seinen Medikamenten gegen Krebs und seltene Krankheiten sorgt beim Pharmakonzern Astrazeneca…

AstraZeneca raises 2024 outlook on strong Q3 By Investing.com

AstraZeneca raises 2024 outlook on strong Q3…

AstraZeneca shares present an opportunity after strong Q3 results

The UK’s second-largest listed company by market cap (at the time of writing) presents an opportunity for investors after releasing…

Astrazeneca plant Milliardeninvestionen in USA - 'Attraktives Geschäftsumfeld'

CAMBRIDGE (dpa-AFX) - Nur wenige Tage nach den richtungsweisenden US-Präsidentschaftswahlen hat der britisch-schwedische Pharmakonzern Astrazeneca …

Astrazeneca plant Milliardeninvestionen in USA - Attraktives Geschäftsumfeld

CAMBRIDGE (dpa-AFX) - Nur wenige Tage nach den richtungsweisenden US-Präsidentschaftswahlen hat der britisch-schwedische Pharmakonzern Astrazeneca dort milliardenschwere Investitionen angekündigt.…

AstraZeneca lifts 2024 revenue and profit forecast after Q3 beat By Reuters

AstraZeneca lifts 2024 revenue and profit forecast after Q3 beat…

Geschäfte florieren: Pharmahersteller Astrazeneca hebt Jahresziele erneut an

CAMBRIDGE (dpa-AFX) - Eine hohe Nachfrage vor allem nach seinen Medikamenten gegen Krebs und seltene Krankheiten…

AstraZeneca invests $3.5 billion in US

12 November 2024 AstraZeneca invests $3.5 billion in R&D and manufacturing in the United States AstraZeneca today announces $3.5 billion of capital investment…

9M and Q3 2024 Results

AstraZeneca 12 November 2024 9M and Q3 2024 results Upgrade to full year 2024 guidance underpinned by strong underlying growth momentum Revenue and EPS…

Dato-DXd new BLA submitted, NSQ BLA withdrawn

12 November 2024 Datopotamab deruxtecan new BLA submitted for accelerated approval in the US for patients with previously treated advanced EGFR-mutated non-small…

AstraZeneca Beats on Q3 Earnings, Ups 2024 View, to Invest $3.5B in US

AZN beats third-quarter estimates for earnings and sales. It raises its sales and profit outlook for 2024 for the second…

AstraZeneca’s China-Fueled Plunge May Be Difficult to Shake Off

AstraZeneca Plc started the week with a market valuation of about £171 billion ($222 billion). By the close on Thursday…

AstraZeneca: Contrarian Buy After The China Challenge (Rating Upgrade)

…

AstraZeneca Says Current, Former Executives Involved in China Probe

Two current and two former senior AstraZeneca Plc executives in the group’s China unit are under investigation in a probe…

AstraZeneca Aktie: Kursrückgang übertrieben

Toronto (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von BMO Capital Markets: 1. Überblick über die Situation AstraZeneca plc (ISIN: GB0009895292, WKN: 886455, Ticker-Symbol: ZEG, London…

ANALYSE-FLASH: Deutsche Bank Research hebt Astrazeneca auf Hold

FRANKFURT (dpa-AFX) - Deutsche Bank Research hat Astrazeneca bei einem unveränderten Kursziel von 10500 Pence von "Sell" auf "Hold"…

ANALYSE-FLASH: Deutsche Bank Research hebt Astrazeneca auf 'Hold'

FRANKFURT (dpa-AFX) - Deutsche Bank Research hat Astrazeneca bei einem unveränderten Kursziel von 10500 Pence…

AstraZeneca Aktie: China-Bedenken übertrieben - Kursrückgang als Kaufchance!

Charlotte (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von BofA Securities: Aktuelle Bewertung Die Analysten von BofA Securities stufen die Aktie von AstraZeneca plc (ISIN: GB0009895292,…

Buy, Sell, or Hold AstraZeneca Stock? Key Tips Ahead of Q3 Earnings

AstraZenecas key medicines, mainly cancer drugs, Lynparza, Tagrisso and Imfinzi, and diabetes medicine Farxiga are expected to have driven the…

AstraZeneca shares fall on report of potential China probe fallout

AstraZeneca shares recorded their worst day since March 2020.…

FIVE at FIVE: Primark profits up; AstraZeneca, FTSE 100 slip; Trump trades higher; ASOS losses escalate

1. Primark owner ABF hikes dividend, buyback as profit jumps “We delivered a substantial improvement in profitability, excellent cash generation…

AstraZeneca sheds £15bn in value on weight loss drug data, China fraud report

AstraZeneca PLC (LSE:AZN) shed £15 billion in value on Tuesday following early data on its weight loss drugs and reports dozens…

GOLDMAN SACHS stuft ASTRAZENECA auf Buy

NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für Astrazeneca mit einem Kursziel von 16046 Pence…

UBS stuft ASTRAZENECA auf Sell

ZÜRICH (dpa-AFX Analyser) - Die schweizerische Großbank UBS hat die Einstufung für Astrazeneca auf "Sell" mit einem Kursziel von 11.300…

Total Voting Rights

1 November 2024 15:00 GMT Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct…

AstraZeneca says its China operations president under investigation

AstraZenecas China president is under investigation and is cooperating with Chinese authorities, the company said on Wednesday, sending shares down…

AZN China President under investigation

This announcement contains inside information 30 October 2024 AstraZeneca China President currently under investigation Leon Wang, Executive Vice President International and AstraZeneca China…